← Leaderboards
Grant D Barish
Jesse Brown Va Medical Center
$4,975,800
Attributed
$7,517,028
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$7,517,028 · 4
VA$0 · 1
By mechanism
R01$6,817,820 · 2
K08$609,332 · 1
F32$89,876 · 1
I01$0 · 1
Top collaborators
- Serdar E Bulun5 shared
- Debabrata Chakravarti5 shared
- Jun S Song5 shared
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularGenesGenetic TranscriptionMetabolismIn VivoPhysiologicalRegulationBcl6 GenePathway InteractionsInsightChip-SeqHistonesMorbidity - Disease RateGeneticBaseLipidsKnockout MiceProteinsComplexNuclear ReceptorsRepressionEpigenomicsPlayGenome-Wide
Grant awards (26)
Nuclear Repressors in Genomic Control of Healthful Obesity$420,683
R01 · FY2024 · DK · contact PI
Transcriptional Control of Skeletal Muscle Atrophy$0
I01 · FY2024 · VA · contact PI
Nuclear Repressors in Genomic Control of Healthful Obesity$438,212
R01 · FY2023 · DK · contact PI
Transcriptional Control of Skeletal Muscle Atrophy$0
I01 · FY2023 · VA · contact PI
Nuclear Repressors in Genomic Control of Healthful Obesity$438,212
R01 · FY2022 · DK · contact PI
Transcriptional Control of Skeletal Muscle Atrophy$0
I01 · FY2022 · VA · contact PI
Nuclear Repressors in Genomic Control of Healthful Obesity$438,212
R01 · FY2021 · DK · contact PI
Transcriptional Control of Skeletal Muscle Atrophy$0
I01 · FY2021 · VA · contact PI
Integrative Genomics, Epigenomics and Bioinformatics Analyses of Human Uterine Fibroids$671,053
R01 · FY2020 · HD
Nuclear Repressors in Genomic Control of Healthful Obesity$337,962
R01 · FY2020 · DK · contact PI
Integrative Genomics, Epigenomics and Bioinformatics Analyses of Human Uterine Fibroids$673,803
R01 · FY2019 · HD
Nuclear Repressors in Genomic Control of Healthful Obesity$338,422
R01 · FY2019 · DK · contact PI
Integrative Genomics, Epigenomics and Bioinformatics Analyses of Human Uterine Fibroids$676,552
R01 · FY2018 · HD
Nuclear Repressors in Genomic Control of Healthful Obesity$338,860
R01 · FY2018 · DK · contact PI
Integrative Genomics, Epigenomics and Bioinformatics Analyses of Human Uterine Fibroids$678,468
R01 · FY2017 · HD
Nuclear Repressors in Genomic Control of Healthful Obesity$339,278
R01 · FY2017 · DK · contact PI
Integrative Genomics, Epigenomics and Bioinformatics Analyses of Human Uterine Fibroids$688,428
R01 · FY2016 · HD
Nuclear Repressors in Genomic Control of Healthful Obesity$339,675
R01 · FY2016 · DK · contact PI
Repressor-PPAR Interactions in Inflammation and Atherosclerosis$123,537
K08 · FY2013 · HL · contact PI
Repressor-PPAR Interactions in Inflammation and Atherosclerosis$110,035
K08 · FY2012 · HL · contact PI
Repressor-PPAR Interactions in Inflammation and Atherosclerosis$13,502
K08 · FY2012 · HL · contact PI
Repressor-PPAR Interactions in Inflammation and Atherosclerosis$123,537
K08 · FY2011 · HL · contact PI
Repressor-PPAR Interactions in Inflammation and Atherosclerosis$120,726
K08 · FY2010 · HL · contact PI
Repressor-PPAR Interactions in Inflammation and Atherosclerosis$117,995
K08 · FY2009 · HL · contact PI
PPARs in Atherosclerosis and Immunity$38,328
F32 · FY2006 · DK · contact PI
PPARs in Atherosclerosis and Immunity$51,548
F32 · FY2005 · DK